| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Gm-infusion Capital | President
1 company
Daniel Woolson is VP, Gm-infusion Capital at ICUI. Daniel Woolson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.8M at current prices.
Historically, Daniel Woolson's trades have earned a middling insider score of 56/100 across 7 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of -8.1%.
The ICUI filings lean toward selling, a net 21,194 shares.
Daniel Woolson has 25 Form 4 filings on record from March 2017 to August 2026, all as VP, Gm-infusion Capital at ICU Medical (ICUI), 2017–2026.
The 69 reported transactions were 28 option exercises, 28 tax withholdings, 9 open-market sales and 4 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 9 sales worth about $3.5M.
The largest open-market sale was 5,417 shares of ICUI at an average $181.33 on August 13, 2026, about $982K.
None of the 7 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | ICUI Icu Medical, Inc. | VP, Gm-infusion Capital | Sell | 5,417 | $181.33 | $982,264.61 | -24.1% | - | - | |
| May 22, 2026 | ICUI Icu Medical, Inc. | President | Sell | 2,123 | $132.21 | $280,684.80 | -8.6% | +36.9% | - | |
| Nov 25, 2025 | ICUI Icu Medical Inc/de | VP, Gm-infusion Capital | Sell | 2,897 | $152.35 | $441,364.32 | -20.4% | -0.2% | - | |
| Dec 6, 2024 | ICUI Icu Medical Inc/de | VP, Gm-infusion Capital | Sell | 2,241 | $156.25 | $350,158.49 | -17.1% | -8.7% | -8.5% | |
| Aug 30, 2024 | ICUI Icu Medical Inc/de | VP, Gm-infusion Capital | Sell | 2,502 | $163.22 | $408,370.19 | -16.0% | -0.8% | -22.8% | |
| Mar 15, 2024 | ICUI Icu Medical Inc/de | VP, Gm-infusion Capital | Sell | 791 | $98.27 | $77,732.76 | -5.4% | +15.7% | +46.3% | |
| Dec 1, 2023 | ICUI Icu Medical Inc/de | VP, Gm-infusion Capital | Sell | 1,729 | $88.03 | $152,196.26 | -14.9% | +19.6% | +79.5% | |
| Feb 2, 2023 | ICUI Icu Medical Inc/de | VP, Gm-infusion Capital | Sell | 1,731 | $200.00 | $346,200.00 | -15.9% | -5.3% | -54.1% | |
| May 24, 2018 | ICUI Icu Medical Inc/de | VP, Gm-infusion Capital | Sell | 1,763 | $273.67 | $482,479.68 | -100% | - | - |